Yvonne Elisabeth Axelsson
Directeur Financier/CFO chez CareDx International (Private Equity)
Profil
Yvonne Elisabeth Axelsson is currently the Director at CareDx AB.
She is also the Chief Financial Officer at CareDx International (Private Equity), a position she has held since 2011.
Previously, she has worked as a Director at Olerup International AB and AbSorber AB.
She also served as the Chief Financial Officer at CareDx International AB from 2010 to 2012.
Postes actifs de Yvonne Elisabeth Axelsson
| Sociétés | Poste | Début |
|---|---|---|
CareDx International (Private Equity)
 CareDx International (Private Equity) Investment ManagersFinance Allenex (Private Equity) (Allnex PE) is the private equity division of LinkMed AB (ST: LMED) in Sweden. Located in Stockholm, the firm was formerly known as LinkMed Private Equity, founded by Ingemar Lagerlöf in 1998. To assure the continued growth of their investee companies, Allnex PE has assembled a network of medical and managerial resources, divided into Corporate Operational Functions (Board and Management Team) and the Venture Management Network (Business Network and Scientific Advisory Board). The Venture Management Network provides guidance and strategic expertise to investee companies. | Directeur Financier/CFO | 01/01/2005 |
CareDx AB
 CareDx AB Medical SpecialtiesHealth Technology CareDx AB develops reagents and kits for low and high resolution human leukocyte antigen typing. Its products include Olerup SSP, Olerup QTYPE, Olerup XM-ONE, Olerup SBT and Olerup Gamma-Type. The comaony was founded by Olle Olerup in 1992 and is headquartered in Saltsjobaden, Sweden. | Directeur/Membre du Conseil | - |
Anciens postes connus de Yvonne Elisabeth Axelsson
| Sociétés | Poste | Fin |
|---|---|---|
AbSorber AB
 AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | - |
Olerup International AB
 Olerup International AB BiotechnologyHealth Technology Olerup International AB distributes molecular diagnostic products and services for human leukocyte antigen (HLA) typing and antibody detection. It offers transplant diagnostics and supportive software. The firm provides products and services for bone marrow and organ transplantation. Its HLA portfolio consists of two product lines, Sequence Specific Primer Genomic HLA Typing and Sequencing Based Typing. The company was founded in 2009 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | - |
| ALLENEX AB | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
CareDx International AB
 CareDx International AB BiotechnologyHealth Technology CareDx International AB engages in the development, manufacture, and sale of products for transplantation of blood stem cells and organs. It offers tissue typing products and products for antibody detection. The company was founded by Ingemar Lagerlöf in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
CareDx International (Private Equity)
CareDx International (Private Equity) Investment ManagersFinance Allenex (Private Equity) (Allnex PE) is the private equity division of LinkMed AB (ST: LMED) in Sweden. Located in Stockholm, the firm was formerly known as LinkMed Private Equity, founded by Ingemar Lagerlöf in 1998. To assure the continued growth of their investee companies, Allnex PE has assembled a network of medical and managerial resources, divided into Corporate Operational Functions (Board and Management Team) and the Venture Management Network (Business Network and Scientific Advisory Board). The Venture Management Network provides guidance and strategic expertise to investee companies. | Finance |
AbSorber AB
AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
CareDx AB
CareDx AB Medical SpecialtiesHealth Technology CareDx AB develops reagents and kits for low and high resolution human leukocyte antigen typing. Its products include Olerup SSP, Olerup QTYPE, Olerup XM-ONE, Olerup SBT and Olerup Gamma-Type. The comaony was founded by Olle Olerup in 1992 and is headquartered in Saltsjobaden, Sweden. | Health Technology |
Olerup International AB
Olerup International AB BiotechnologyHealth Technology Olerup International AB distributes molecular diagnostic products and services for human leukocyte antigen (HLA) typing and antibody detection. It offers transplant diagnostics and supportive software. The firm provides products and services for bone marrow and organ transplantation. Its HLA portfolio consists of two product lines, Sequence Specific Primer Genomic HLA Typing and Sequencing Based Typing. The company was founded in 2009 and is headquartered in Stockholm, Sweden. | Health Technology |
